Robert Besser
22 Mar 2023, 05:35 GMT+10
WASHINGTON D.C.: The Alzheimer's Association is lobbying Congress to enable early Medicare coverage of a new class of drugs, beginning with Leqembi, which promise to slow the spreading of the disease in patients.
For this purpose, the group has sent 1,000 people diagnosed with or caring for someone with Alzheimer's to meet with all 535 members of Congress across the US.
In interviews with four national and local officials, the grassroots lobbying campaign is being led by state-based chapters of the Alzheimer's Association, with the aim of persuading the Medicare health program for people aged 65 and older to provide "full and unrestricted coverage" to the drugs when they first reach the US market, under an accelerated approval from the Food and Drug Administration (FDA).
Once the drugs receive full commercial approval from the FDA, wider Medicare coverage will become available, but this process will require more data from drugmakers and could take months.
However, the Alzheimer's Association stressed that patients not have the time to wait and hundreds of thousands of elderly people with mild dementia may progress to a more advanced stage of the disease during that period, resulting in their no longer being eligible for the new drugs.
"Treatments taken in the early stages of Alzheimer's would allow people more time to participate in daily life, remain independent and make health care decisions for their future," said Alzheimer's Association President Joanne Pike, in a statement.
After the first of the new drugs, Japan's Eisai and Biogen's Leqembi, showed evidence in trials that they could slow the advance of Alzheimer's in early stages of the disease, they won FDA approval in January under an accelerated review process. Eisai priced the drug at $26,500 annually.
Meanwhile, the US Centers for Disease Control and Prevention has published data that showed that an estimated 6.5 million Americans are living with Alzheimer's disease, which is the fifth leading cause of death for adults over 65.
Get a daily dose of The US News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to The US News.
More InformationVICTORIA, Texas: This week, U.S. District Judge Drew Tipton in Victoria, Texas, ruled that President Joe Biden did not have ...
WASHINGTON D.C.: The National Transportation Safety Board (NTSB) said it is investigating a JetBlue flight on Monday that experienced sudden ...
SEOUL, South Korea: Marking a tougher stand against North Korea, South Korea held its first large-scale military parade in over ...
WASHINGTON D.C. After hundreds of deaths overseas from contaminated cough syrups, the U.S. Food and Drug Administration (FDA) has cracked ...
EL PASO, Texas: Over the weekend, Oscar Leeser, Mayor of El Paso, said that the surge in migrants crossing the ...
HONG KONG: This week, Ronson Chan, chairman of the Hong Kong Journalists Association, was sentenced to five days jail for ...
NEW YORK, New York - Stock prices were punctured Friday bringing to an end the 'flash in the pan' rally ...
WASHINGTON D.C. Due to internal brake fluid leaks that can cause an electrical short and could lead to engine fires, ...
WASHINGTON D.C. As part of its efforts to remove goods made by Uyghur forced labor from the U.S. supply chain, ...
LONDON, UK: In August, global production of primary aluminum hit an all-time high, with production running at an annualized rate ...
NEW YORK, New York - Easing pressure on U.S. Treasury yields boost stocks on American markets Thursday. Gains however were ...
DEARBORN, Michigan: Due to concerns about its ability to operate competitively while it is locked in broader union contract negotiations, ...